Compare SCLX & AVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCLX | AVX |
|---|---|---|
| Founded | 2011 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.9M | 30.8M |
| IPO Year | 2020 | 2020 |
| Metric | SCLX | AVX |
|---|---|---|
| Price | $2.06 | $4.41 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 40.4K | ★ 243.5K |
| Earning Date | 11-13-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 92.55 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $30,253,000.00 | $2,340,811.00 |
| Revenue This Year | $118.16 | $18,042.77 |
| Revenue Next Year | $186.31 | $12.21 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3348.10 |
| 52 Week Low | $2.27 | $0.35 |
| 52 Week High | $27.00 | $7.38 |
| Indicator | SCLX | AVX |
|---|---|---|
| Relative Strength Index (RSI) | 14.46 | 46.20 |
| Support Level | N/A | $3.02 |
| Resistance Level | $7.77 | $6.25 |
| Average True Range (ATR) | 0.23 | 0.71 |
| MACD | -0.01 | -0.13 |
| Stochastic Oscillator | 2.53 | 25.63 |
Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
AVAX One Technology Ltd is a digital infrastructure company focused on digital asset and computing infrastructure. The Company builds modular data centers in regions with access to energy resources, using behind-the-meter generation and microgrid design to provide compute capacity for AI and high-performance computing (HPC) workloads. In addition, the company mines Bitcoin in Alberta and Ohio, operating at a hashrate of approximately 300 PH/s. The Company also maintains an Avalanche digital asset treasury, accumulating AVAX and generating onchain yield through native staking and ecosystem participation.